Clarithromycin: Difference between revisions
No edit summary |
(prior error) |
||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: bacteriostatic | ||
*Dosage Forms: | *Dosage Forms: | ||
*Common Trade Names: | *Common Trade Names: Biaxin | ||
==Adult Dosing== | ==Adult Dosing== | ||
| Line 20: | Line 20: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*Liver disease | |||
*Renal disease | |||
==Adverse Reactions== | ==Adverse Reactions== | ||
Revision as of 08:53, 8 August 2015
General
- Type: bacteriostatic
- Dosage Forms:
- Common Trade Names: Biaxin
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- Liver disease
- Renal disease
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
Source
- ↑ Sanford Guide to Antimicrobial Therapy 2014